5 Leukemia Clinical Trials in Clermont, FL (2026)

Q: How do I join a clinical trial in Clermont?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Clermont research site will contact you.

Recruiting Leukemia Studies in Clermont

NCT05236114Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition t...

Clermont, FL1,200 participantsTempus AI

View Study Details

NCT05947851Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypothese...

Clermont, FLPHASE3735 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06712355Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

This is a Phase III, multisite, randomized, double-blinded study to investigate pumitamig (BNT327) combined with chemotherapy (etoposide/carboplatin) compared to atezolizumab combined with chemotherap...

Clermont, FLPHASE3621 participantsBioNTech SE

View Study Details

NCT07218146Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer....

Clermont, FLPHASE3480 participantsZai Lab (Shanghai) Co., Ltd.

View Study Details

NCT06095505Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after treatment with one platinum-...

Clermont, FLPHASE2120 participantsPuma Biotechnology, Inc.

View Study Details

About Leukemia Clinical Trials in Clermont

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 5 leukemia clinical trials recruiting participants in Clermont, FL. These studies are seeking a combined 3,156 participants. Research is being sponsored by Tempus AI, Merck Sharp & Dohme LLC, BioNTech SE and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Clermont — FAQ

Are there leukemia clinical trials in Clermont?

Yes, there are 5 leukemia clinical trials currently recruiting in Clermont, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Clermont?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Clermont research site will contact you about next steps.

Are clinical trials in Clermont free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Clermont studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 5 active trials in Clermont are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated October 15, 2026 from ClinicalTrials.gov